TransMedics Group, Inc. Common Stock
$88.09
$2.23 (+2.60%)
$85.47Day Range$90.67
Key Statistics
Market Cap
$3.05B
Shares Outstanding
34.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 2, 2019
Round Lot
100
Locale
US
Trading Data
Day Open
$86.39
Day High
$90.67
Day Low
$85.47
Volume
942.9K
VWAP
$88.50
Prev Close
$85.86
Transactions
--
Acc. Volume
--
About TransMedics Group, Inc. Common Stock
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSSIC 3845898 employees200 MINUTEMAN ROAD, ANDOVER, MA, 01810(978) 552-0900IPO May 2, 2019US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001756262
- Composite FIGI
- BBG00NZ6J685
- Share Class FIGI
- BBG00NZ6J701
- Ticker Root
- TMDX
- SIC Code
- 3845
About TransMedics Group, Inc. Common Stock (TMDX) Stock
TransMedics Group, Inc. Common Stock (TMDX) closed the 2026-09-15 session at $88.09, up 2.60% versus the previous close (+2.23). The stock opened at $86.39 and traded between $85.47 and $90.67 during that session. Session trading volume was 943K shares. The volume-weighted average price (VWAP) is $88.50.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
TransMedics Group, Inc. Common Stock has a market capitalization of $3.05 billion. The company operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry classification. TMDX is listed on the XNAS exchange. The company employs approximately 898 people. TransMedics Group, Inc. Common Stock is headquartered in ANDOVER, MA. The recorded listing date is 2019-05-02.
On this page you can find market TMDX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector.